ORCHIDPHAR

Orchid Pharma Limited has informed the Exchange regarding 'Update on'the implementation of the approved resolution plan for the Corporate Debtor'.

Orchid Pharma Limited has informed the Exchange about Approval of Resolution plan by NCLT,Chennai

Orchid Pharma Limited has informed the Exchange regarding Disclosure for Related Party Transactions under Regulation 23(9) of SEBI (LODR) regulations, 2015 for the half year ended March 31,2019

Orchid Pharma Limited has informed the Exchange about the retirement of CFO and CS

Orchid Pharma Limited has informed the Exchange about update on the resolution process

Orchid Pharma Limited has informed the Exchange regarding Reasons for Delayed submission of Financial Results

Orchid Pharma Limited has informed the Exchange regarding 'Update on e-voting by creditors'.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on Jun 03, 2019.

Orchid Pharma Limited has informed the Exchange about updates on the meeting of the Committee of Creditors

Orchid Pharma Limited has informed the Exchange regarding Outcome of Committee Meeting held on May 24, 2019.

Orchid Pharma Limited has informed the Exchange regarding 'Non-applicability of the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 in respect of fund raising by issuance of Debt Securities by Large Entity '.

Orchid Pharma Limited has informed the Exchange about updates on Corporate Insolvency Resolution Process

Orchid Pharma Limited has informed the Exchange regarding ' ANDA APPROVAL FROM US FDA FOR RISEDRONATE SODIUM TABLETS'.

Orchid Pharma Limited has informed the Exchange about updates on Committee of Creditors meeting

The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.

Orchid Pharma Limited has informed the Exchange about updates on meeting of Committee of Creditors

Orchid Pharma Limited has informed the Exchange regarding the Code of Conduct under SEBI(PIT) Reg., 2015

ORCHIDPHAR: The Exchange had sought clarification from Orchid Pharma Limited with respect to announcement dated 01-Mar-2019, regarding 'Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015'.".On basis of above the Company is required to clarify following:1. Any other material information not involving commercial secrets2. Salient features, not involving commercial secrets, of the resolution plan approved by the Tribunal, in such form as may be specified3. Approval of resolution plan by the Tribunal or rejection, if applicable4. Filing of resolution plan with the Tribunal5. Number

ORCHIDPHAR:The Exchange has sought clarification from Orchid Pharma Limited with respect to announcement dated 01-Mar-2019, regarding " Orchid Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015'.". On basis of above the Company is required to clarify following: 1. Any other material information not involving commercial secrets<br> 2. Salient features, not involving commercial secrets, of the resolution plan approved by the Tribunal, in such form as may be specified<br> 3. Approval of resolution plan by the Tribunal or rejecti

Orchid Pharma Limited has informed the Exchange regarding Publication for submission of Expression of Interest under Insolvency and Bankruptcy Code,2016

Orchid Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015'.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on February 13, 2019.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on January 29, 2019.

Orchid Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on December 12, 2018

Orchid Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on December 12, 2018

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 30, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 30, 2018.

Orchid Pharma Limited has informed the Exchange that��the Register of Members and Share Transfer Books of the Company shall remain closed from December 6, 2018 to December 12, 2018 (both days inclusive) for the purpose of Annual General Meeting of the Company is scheduled to be held on December 12, 2018.

Orchid Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on December 12, 2018

Orchid Pharma Limited has informed the Exchange regarding 'news paper cutting '.

Orchid Pharma Limited has informed the Exchange regarding "Intimation about the Extension of Annual General Meeting of the Company".

Orchid Pharma Limited has informed the Exchange regarding a press release dated September 21, 2018, titled "Approval of Resolution Plan by NCLT, Chennai".

The Exchange has sought clarification from Orchid Pharma Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -2. Consolidated Reconciliation of Equity not submitted The response of the Company is awaited.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

Orchid Pharma Limited has informed the Exchange regarding 'DISCLOSURE UNDER REGULATION 30 OF THE SEBI(LODR) REGULATIONS,2015'.

Orchid Pharma Limited has informed the Exchange regarding 'Appointment of NSDL as the Designated Depository for the purpose of System Driven Disclosure in Securities Market'.

Orchid Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015.'.

Orchid Pharma Limited has informed the Exchange that'Orchid has received EU GMP (Good Manufacturing Practice) certification based on the inspection of the Orchid's API manufacturing facility located at SIDCO Industrial Estate, Alathur, Kancheepuram District, 603 110, Tamil Nadu, India.'.

Orchid Pharma Limited has informed the Exchange regarding 'DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS,2015'.

Orchid Pharma Limited has informed the Exchange regarding 'FORM G -INVITATION FOR RESOLUTION PLANS '.

Orchid Pharma Limited has informed the Exchange regarding 'UPDATES-COMMITTEE OF CREDITORS MEETING'.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on April 17, 2018.

SBICAP Trustee Company Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Rajagopal K has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K Raghavendra Rao For and on behalf of Promoters & Promoter Group has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.